The FamilyPso tool was created and validated to measure the burden of psoriasis on patients' partners, including domains like ...

There’s a new ‘bonus’ tax deduction worth $6,000 for older taxpayers — here’s who qualifies ...

Treatment with TNF inhibitors may be beneficial over phototherapy in reducing the risk for psoriatic arthritis in patients ...

Promising Psoriasis Pipeline Therapies such as Hypericin, EDP1815, Cetaphil, AX-158, HAT1 topical solution, Calcipotriol, ARQ ...

Bill Streicher/Imagn Images Dallas Goedert has dealt with plaque psoriasis, an autoimmune disease that causes raised, scaly patches of skin, since he was 10 years old. He says the oral medication ...

A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

There are several types of psoriasis, and each can look and feel a little different. The most common is plaque psoriasis: It leads to thick, raised patches of skin on areas like your scalp, lower back ...

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the treatment of plaque psoriasis of the scalp and body in adult and ...

Zoryve is also available in a 0.3% cream formulation for the treatment of plaque psoriasis, including intertriginous areas, in adult and pediatric patients 6 years of age and older.

Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.

Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill ...

84% of adolescents with moderate-to-severe plaque psoriasis treated with investigational icotrokinra achieved clear or almost clear skin (IGA 0/1) at Week 16 ...